Featured Post

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA)

Twenty Practical Steps to Better Corporate Governance | The Corporate Secretaries International Association (CSIA) Please click the li...

Showing posts with label 2017 at 06:25PM. Show all posts
Showing posts with label 2017 at 06:25PM. Show all posts

Monday, June 12, 2017

Cheesecake Factory Expands Amid a Challenging Environment

http://ift.tt/2riix1a

A challenging industry backdrop has been hampering the performance of most restaurant chains and The Cheesecake Factory Inc. CAKE is no exception.

Nonetheless, Cheesecake Factory has been expanding in the domestic as well as international markets, despite a soft consumer spending environment in the U.S. restaurant space. The company remains focused on opening its restaurants at high grade sites to hit targeted returns.

Recently, the company announced the opening of a new restaurant in The Shops at Riverside in Hackensack, N.J. It is located at the south end of The Shops at Riverside at 390 Hackensack Ave., Suite 155, Hackensack, NJ 07601. In fact, this restaurant is a relocation of the company’s former location on the west side of The Shops at Riverside.

The restaurant offers over 250 menu items including the company’s signature 50 lower calorie SkinnyLicious dishes and new Super Foods salads that are handmade with fresh ingredients. More than 50 cheesecakes and desserts are also available here.

Cheesecake Factory currently has 207 company-owned restaurants: 193 under The Cheesecake Factory brand, 13 under the Grand Lux cafĂ© brand and one under the RockSugar Pan Asian Kitchen brand. Internationally, the company operates 16 restaurants under The Cheesecake Factory brand in the Middle East, Mexico and China under licensing agreements.  It operates two bakery production facilities as well.

Besides the domestic market, the company is foraying into lucrative markets like the Middle East, North Africa, Central and Eastern Europe, Russia, Turkey, Mexico, Kuwait and Lebanon and Chile, of late. In 2017, the company plans to open eight company-owned restaurants along with four to five restaurants internationally under licensing agreements. In addition, Cheesecake Factory has marked its entry in China, East Asia, a region known for its economic growth and healthy investment returns.

Notably, in first-quarter 2017, the company posted the 29th consequent quarter of positive comps at The Cheesecake Factory restaurants. Going forward, various initiatives to boost sales and traffic volume like menu innovation, roll-out of an improved server training program, launch of mobile payment app and increased focus on delivery service should aid in keeping up the trend of positive comps.

However, we note that the shares of the company have compared unfavorably with the Zacks categorized Retail-Restaurants industry in the last six months. While, the industry witnessed a gain of 9%, Cheesecake Factory shares have recorded a decline of 8.6% in the same time period.

Thus, continued slowdown in the industry at large remains a potent headwind to the company’s top line while high costs may hurt profits.

Nevertheless, it is to be noted that Cheesecake Factory is one of the most recognized upscale casual restaurants operating in the U.S. Its differentiated menu, operational distinction and unique ambiance appeal to customers.

We thus expect this Zacks Rank #4 (Sell) company’s continuous expansion plans to add immensely to the top line and boost its overall performance as well.

Stocks to Consider

Better-ranked stocks in this sector include Dave & Buster’s Entertainment, Inc. PLAY, Darden Restaurants, Inc. DRI, and Fogo de Chao, Inc. FOGO. While Dave & Buster’s sports a Zacks Rank #1 (Strong Buy), Darden and Fogo de Chao carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Dave & Buster’s earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, with an average beat of 30.50%. Meanwhile, for fiscal 2017, earnings per share (EPS) is projected to witness a rise of 22.9%.

Darden’s earnings surpassed the Zacks Consensus Estimate in each of the last four quarters, with an average beat of 3.35%. Further, for fiscal 2017, EPS is expected to grow nearly 13%.

The Zacks Consensus Estimate for Fogo de Chao’s 2017 earnings moved up 2.2%, over the past 60 days. Moreover, for 2017, EPS is expected to improve 6.4%.

More Stock News: This Is Bigger than the iPhone!  
                 
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020. Click here for the 6 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
The Cheesecake Factory Incorporated (CAKE): Free Stock Analysis Report
 
Darden Restaurants, Inc. (DRI): Free Stock Analysis Report
 
Dave & Buster’s Entertainment, Inc. (PLAY): Free Stock Analysis Report
 
Fogo de Chao, Inc. (FOGO): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 12, 2017 at 06:21PM

http://ift.tt/2s2tVeF

from Zacks Equity Research

http://ift.tt/2s2tVeF


Merck’s Diabetes Drug Meets Primary Endpoint in Key Studies

http://ift.tt/2s28D0H

Merck & Co., Inc. MRK and partner Pfizer Inc. PFE announced that its pipeline candidate, ertugliflozin, met primary endpoints in two late stage studies evaluating ertugliflozin in adults with Type 2 diabetes. The results were presented at the Scientific Sessions of the American Diabetes Association (ADA) in San Diego.

Marketing applications for ertugliflozin, one as a monotherapy and one each for fixed-dose combinations ertugliflozin/Januvia and ertugliflozin/metformin, are under review with the FDA and the European Medicines Agency. The FDA is expected to announce its decision in December this year.

Merck’s shares are up 9.4% so far this year, comparing unfavorably with an increase of 10.8% witnessed by the Zacks classified Large-Cap Pharma industry.

The two late stage studies – VERTIS MET and VERTIS SITA – evaluated the combination of ertugliflozin (5 mg and 15 mg daily) with metformin or Merck’s another diabetes drug, Januvia (100 mg), respectively. Both the studies compared efficacy and safety of the combination therapies with a placebo.

Data from the studies showed that ertugliflozin, when added to Januvia or metformin, led to A1C (a measure of average blood glucose) reduction in patients with type II diabetes. The drug met the key secondary endpoints of the studies as well. Overall adverse event (AE) rates were also low in both the dosage arms of ertugliflozin compared to placebo. Moreover, the candidate in both the studies achieved significant reductions in fasting plasma glucose (FPG), body weight, systolic blood pressure (SBP) and diastolic blood pressure (DBP), when compared with placebo.

Ertugliflozin is an oral sodium glucose cotransporter (SGLT2) inhibitor to help improve glycemic control in type 2 diabetes patients.

The companies are evaluating the candidate in nine phase III programs under the VERTIS program in adults with type 2 diabetes. This includes VERTIS CV study evaluating its non-inferiority to placebo in cardiovascular problems including death or nonfatal myocardial infarction or nonfatal stroke.

Merck’s diabetes franchise includes drugs like Januvia and Janumet (Januvia + metformin HCl). The franchise recorded sales of $1.3 billion in the first quarter of 2017, down 5% from the year-ago due to the timing of customer purchases in the U.S.

However, we note that the diabetes space is highly crowded with drugs like Eli Lilly & Company’s LLY Tradjenta and Jardiance and Novo Nordisk A/S’s NVO Victoza and Tresiba among others. Merck’s diabetes portfolio will get a boost after the approval of ertugliflozin therapies.

Zacks Ranks

Merck currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020. Click here for the 6 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer, Inc. (PFE): Free Stock Analysis Report
 
Eli Lilly and Company (LLY): Free Stock Analysis Report
 
Novo Nordisk A/S (NVO): Free Stock Analysis Report
 
Merck & Company, Inc. (MRK): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 12, 2017 at 06:21PM

http://ift.tt/2s2aSAV

from Zacks Equity Research

http://ift.tt/2s2aSAV


Why LendingClub (LC) Could Beat Earnings Estimates Again

http://ift.tt/2rhZzHQ

Looking for a stock that might be in a good position to beat earnings at its next report? Consider LendingClub Corporation LC, a firm in the Financial – Miscellaneous Services industry, which could be a great candidate for another beat.

This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, LC has beaten estimates by at least 10% in both cases, suggesting it has a nice short-term history of crushing expectations.

Earnings in Focus

Two quarters ago, LC expected to post a loss of 9 cents per share, while it actually produced a loss of 8 cents per share, a beat of 11.1%. Meanwhile, for the most recent quarter, the company looked to deliver a loss of 9 cents per share, when it actually saw a loss of 7 cents per share instead, representing a 22.2% positive surprise.

LendingClub Corporation Price and EPS Surprise

LendingClub Corporation Price and EPS Surprise | LendingClub Corporation Quote

Thanks in part to this history, recent estimates have been moving higher for LendingClub. In fact, the Earnings ESP for LC is positive, which is a great sign of a coming beat.

After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for LC, as the firm currently has a Zacks Earnings ESP of +33.33%, so another beat could be around the corner.

This is particularly true when you consider that LC has a great Zacks Rank #2 (Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

When you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that LC could see another beat at its next report, especially if recent trends are any guide.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020. Click here for the 6 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
LendingClub Corporation (LC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 12, 2017 at 06:21PM

http://ift.tt/2rilhvo

from Zacks Equity Research

http://ift.tt/2rilhvo


What Falling Estimates & Price Mean for Unit Corporation (UNT)

http://ift.tt/2s2yYvr

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.

One such stock that you may want to consider dropping is Unit Corporation UNT, which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. A Zacks Rank #5 (Strong Sell) further confirms weakness in UNT.

 A key reason for this move has been the negative trend in earnings estimate revisions. For the full year, we have seen one estimates moving down in the past 30 days, compared with just no upward revisions. This trend has caused the consensus estimate to trend lower, going from 97 cents a share a month ago to its current level of 85 cents.

Also, for the current quarter, Unit Corporation has seen two downward estimate revisions versus no revisions in the opposite direction, dragging the consensus estimate down to 12 cents a share from 19 cents over the past 30 days.    

The stock also has seen some pretty dismal trading lately, as the share price has dropped 8.8% in the past month.

Unit Corporation Price and Consensus

 

Unit Corporation Price and Consensus | Unit Corporation Quote

So, it may not be a good decision to keep this stock in your portfolio anymore, at least if you don’t have a long-time horizon to wait.

If you are still interested in the Oils-Energy sector, you may instead consider a better-ranked stock – Braskem S.A. BAK. The stock currently holds a Zacks Rank #1 (Strong Buy) and may be a better selection at this time. You can see the complete list of today’s Zacks #1 Rank stocks here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don’t buy now, you may kick yourself in 2020.

 Click here for the 6 trades >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Unit Corporation (UNT): Free Stock Analysis Report
 
Braskem S.A. (BAK): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 12, 2017 at 06:21PM

http://ift.tt/2s2kxHT

from Zacks Equity Research

http://ift.tt/2s2kxHT


Is the Options Market Predicting a Spike in Sanofi (SNY) Stock?

http://ift.tt/eA8V8J

Investors in Sanofi SNY need to pay close attention to the stock based on moves in the options market lately. That is because the June 16th, 2017 $30 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?

Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?

Clearly, options traders are pricing in a big move for Sanofi shares, but what is the fundamental picture for the company? Currently, Sanofi is a Zacks Rank #2 (Buy) in the Large Cap Pharmaceuticals industry that ranks in the Top 20% of our Zacks Industry Rank. Over the last 60 days, one analyst has increased their earnings estimates for the current quarter, while none has dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from 70 cents per share to 79 cents per share in that period.

Given the way analysts feel about Sanofi right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?

Each week, our very own Dave Bartosiak gives his top options trades. Check out his recent live analysis and options trade for the TSLA earnings report completely free. See it here Bartosiak: Trading Tesla’s (TSLA) Earnings with Options or check out the embedded video below for more details:

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Sanofi (SNY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 12, 2017 at 06:21PM

http://ift.tt/2rhZ5S8

from Zacks Equity Research

http://ift.tt/2rhZ5S8


Sunday, June 11, 2017

Thursday, June 8, 2017

Not so ‘fake’ news? Comey testimony will confirm reports the White House has tried to knock down

http://ift.tt/eA8V8J
The White House often tries to shoot down unfavorable news reports, but James Comey appears set to back up some of them.

June 08, 2017 at 06:12PM

http://ift.tt/2r5FsfK

from

http://ift.tt/2r5FsfK


Nordstrom shares spike after company announces exploration of going private

http://ift.tt/eA8V8J
Shares of the retailer’s stock soared in premarket trade Thursday following this news.

June 08, 2017 at 06:12PM

http://ift.tt/2s7tVN7

from

http://ift.tt/2s7tVN7


Oil prices fall for second day as concern grows over supply

http://ift.tt/eA8V8J
Oil prices fell to one-month lows after an unexpected surge in U.S. inventories and more Nigerian crude hit the market.

June 08, 2017 at 06:12PM

http://ift.tt/2rXd7Yp

from

http://ift.tt/2rXd7Yp


American Cannabis Company, Inc. Announces It Has Secured A Contract With A New Client In Arkansas

http://ift.tt/eA8V8J

DENVER, CO–(Marketwired – Jun 8, 2017) – American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured its first client in the state of Arkansas. ACC will be working with this client to strategically plan business operations in effort to win a license to legally operate a vertically integrated cannabis business within the state.

June 08, 2017 at 06:19PM

http://ift.tt/2sXmrsu

from

http://ift.tt/2sXmrsu


4 Reasons to Add Kraton Corp (KRA) Stock to Your Portfolio

http://ift.tt/2qZFKB2

Kraton Corporation’s KRA stock looks promising at the moment. The chemical maker, currently carrying a Zacks Rank #1 (Strong Buy), has seen its shares rise roughly 11.5% year to date. We are positive on the company’s prospects and believe that the time is right for you to add the stock to portfolio as it looks promising and is poised to carry the momentum ahead.

What’s Working in Favor of Kraton?

Estimates Northbound: Annual estimates for Kraton have moved north over the past 60 days, reflecting analysts’ confidence on the stock. Over this period, the Zacks Consensus Estimate for 2017 has increased by around 7.6% to $2.13 per share. The Zacks Consensus Estimate for 2018 has also moved up 15.6% over the same timeframe to $3.34.

An Outperformer: Kraton has outperformed the Zacks categorized Chemical-Specialty industry over the past three months. The company’s shares have gained around 18% over this period, compared with roughly 2.9% gain recorded by the industry.  


 

Attractive Valuation: Going by the EV/EBITDA (Enterprise Value/ Earnings before Interest, Tax, Depreciation and Amortization) multiple, which is often used to value chemical stocks, Kraton is currently trading at trailing 12-month EV/EBITDA multiple of 7.44, cheaper compared with the industry average of 23.92.

Growth Drivers: Kraton remains committed to steer organic growth in key markets through state-of-the-art innovation and infrastructure. The company, last month, announced the opening of a hydrogenated styrenic block copolymer (HSBC) plant in Mailiao, Taiwan. The plant will boost the company’s innovation-grade business, especially low molecular weight HSBC products. It will also help Kraton to effectively serve the growing export and Asian markets through higher production capacity of varied grades of HSBC products.

Kraton should also gain from its efforts to reduce costs and debt. The company is making a good progress in its cost reduction initiatives and has achieved $68 million of cost savings in 2016 and another $13 million in the first quarter of 2017. It expects to realize an additional $27 million in cost reductions in the remainder of 2017. Kraton remains on track to deliver $135 million of cost reductions by 2018. The company also plans to cut net debt by $100-$150 million in 2017.

Kraton has also implemented price hikes to address raw material cost inflation and expects full realization of price increases in second-quarter 2017, which will support polymer margins in the quarter.

Kraton Corporation Price and Consensus

 

Kraton Corporation Price and Consensus | Kraton Corporation Quote

Other Stocks to Consider

Other top-ranked stocks in the chemical space include Huntsman Corporation HUN, BASF SE BASFY and The Chemours Company CC, all sporting a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

Huntsman has an expected long-term earnings growth of 7%.

BASF has an expected long-term earnings growth of 8.9%.

Chemours has an expected long-term earnings growth of 15.5%.

3 Top Picks to Ride the Hottest Tech Trend  
                 
Zacks just released a Special Report to guide you through a space that has already begun to transform our entire economy…

Last year, it was generating $8 billion in global revenues. By 2020, it’s predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce “the world’s first trillionaires,” but that should still leave plenty of money for those who make the right trades early. Download Report with 3 Top Tech Stocks >>
 

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BASF SE (BASFY): Free Stock Analysis Report
 
Huntsman Corporation (HUN): Free Stock Analysis Report
 
Chemours Company (The) (CC): Free Stock Analysis Report
 
Kraton Corporation (KRA): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

June 08, 2017 at 06:15PM

http://ift.tt/2siRy56

from Zacks Equity Research

http://ift.tt/2siRy56


Canopy Hotel aims for West Palm Beach, needs foreign investor money – MyPalmBeachPost

http://ift.tt/2sXlost


MyPalmBeachPost
Canopy Hotel aims for West Palm Beach, needs foreign investor money
MyPalmBeachPost
Canopy’s developer needs to raise more money to build the sexy, all-glass hotel set for downtown. Hotel delayed is not hotel denied. A Canopy Hotel still is planned for downtown West Palm Beach, but a construction start will take longer than expected.

and more »

June 08, 2017 at 06:18PM

http://ift.tt/2rZHjSR

from

http://ift.tt/2rZHjSR


Chipotle Breaks Down From Head & Shoulders (CMG)

http://ift.tt/eA8V8J
Chipotle shares broke down from a head and shoulders pattern that could put a halt to their rally this year.

June 08, 2017 at 06:11PM

http://ift.tt/2rZxt3a

from

http://ift.tt/2rZxt3a


The Last #HedgeFund Pit Bull, formidable brigand Paul Singer bit.ly/2siMk9L #activistinvestor #shortseller #corpgov

http://ift.tt/1FwRUqL

0b311a2f9b515154ebca3c216e588eed_normal.

WPWAM
@WillauerProsky

The Last #HedgeFund Pit Bull, formidable brigand Paul Singer bit.ly/2siMk9L #activistinvestor #shortseller #corpgov

June 08, 2017 at 06:18PM

https://twitter.com/WillauerProsky/status/872802465598537728

from WPWAM


Wednesday, June 7, 2017

The Morning Download: Rio Tinto Takes Data Mining to New Depths

http://ift.tt/eA8V8J
Using everything from sensors and data analytics to autonomous vehicles and climate-control systems, Rio Tinto aims to pull ore from more than a mile below ground. The Superior, Ariz. project will cost $6 billion to $8 billion and one day could meet a quarter of the U.S. demand for copper.

June 07, 2017 at 06:25PM

http://ift.tt/2r1ml6M

from Steve Rosenbush

http://ift.tt/2r1ml6M


IDG Contributor Network: After a cyberattack, companies remain vulnerable. What CIOs can do to protect their brands

http://ift.tt/eA8V8J

Here’s a security scenario that’s all too common: A company suffers from a cyberattack, then responds to it promptly and alerts its customers, warning them to change their passwords. But the company remains vulnerable through the very means it uses to alert those customers: Email. In fact, attackers can exploit that vulnerability using email that pretends to be a security warning from the company, targeting customers and wreaking even more damage.

For example, on May 31, popular cloud-based password manager OneLogin announced that it had suffered a serious security breach, and it updated its report the next day with a few more details.

To read this article in full or to leave a comment, please click here

June 07, 2017 at 06:21PM

http://ift.tt/2r54Ayo

from Alexander Garcia-Tobar

http://ift.tt/2r54Ayo


How credit unions can build an innovation culture

http://ift.tt/eA8V8J

Organizations frequently name “innovation” as a key ingredient in their secret sauce for success. In fact, research studying CEOs across the world found 64 percent of those surveyed believe innovation and operational effectiveness are equally important to a company’s success. This seems to indicate an increasing strategic interest in developing innovation cultures.

In its truest sense, an innovation culture is a work environment fostering unorthodox thinking and application. Establishing such a culture requires time, effort and, above all, leadership that supports it. Beyond that, there are a few other important elements for credit unions to consider.

  • Challenging the norm. Credit unions sticking to the status quo quickly stifle any possibility of innovation. They should instead embrace change and challenge processes, even those that are working. Asking questions such as, “How could this be better than it is today?” can have the power to spark creativity.

The post How credit unions can build an innovation culture appeared first on CUInsight.

June 07, 2017 at 06:22PM

http://ift.tt/2s3zbkZ

from Felix Gomez

http://ift.tt/2s3zbkZ


The Market In 5 Minutes

http://ift.tt/eA8V8J

IN THE NEWS

BENZINGA

read more

June 07, 2017 at 06:08PM

http://ift.tt/2sDoBht

from Benzinga News Desk

http://ift.tt/2sDoBht


Credit unions invited to participate in SBA talk on CFPB assessments

http://ift.tt/eA8V8J

Credit unions are invited to participate in the Small Business Administration Office of Advocacy’s upcoming roundtable on financial issues, scheduled for June 26. The roundtable will focus on the Consumer Financial Protection Bureau’s (CFPB) assessment process and recent request for information.

Specifically, it will examine the Consumer Financial Protection Bureau’s recent notices of assessment for mortgage servicing rules and ability-to-repay/qualified mortgage, as well as the bureau’s request for information about the small business lending market.

The event will take place at the SBA’s  Washington, D.C. headquarters on June 26 from 2 to 4 p.m. (ET).

 

The post Credit unions invited to participate in SBA talk on CFPB assessments appeared first on CUInsight.

June 07, 2017 at 06:22PM

http://ift.tt/2s3Kzxh

from John

http://ift.tt/2s3Kzxh